Drug intelligence / Profile preview

MSC-AFP

Development stage
Unknown
Lead developer
Mayo Clinic
Modality
Stem Cell Therapies → Cell Therapies
Administration
Local
01

Overview

MSC-AFP is an investigational autologous cell-based biologic therapy developed by the Mayo Clinic for the treatment of high, transsphincteric cryptoglandular perianal fistulas. The product consists of approximately 20 million autologous adipose-derived mesenchymal stromal cells (MSCs) that are seeded onto a synthetic biomatrix, specifically the Gore Bio-A Fistula Plug. The treatment protocol involves initial drainage and seton placement, followed six weeks later by the implantation of the MSC-loaded plug into the fistula tract. The MSCs are intended to promote healing and fistula closure through their regenerative and immunomodulatory properties, providing a localized therapeutic effect within the fistula environment.

Other names
autologous mesenchymal stromal cell coated fistula plugautologous adipose-derived mesenchymal stromal cellsMSC-loaded Gore Bio-A Fistula Plug

Beyond the preview

Go deeper on MSC-AFP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSC-AFP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call